RB expression confers sensitivity to CDK4/6 inhibitor–mediated radiosensitization across breast cancer subtypes

Standard radiation therapy (RT) does not reliably provide locoregional control for women with multinode-positive breast cancer and triple-negative breast cancer (TNBC). We hypothesized that CDK4/6 inhibition (CDK4/6i) would increase the radiosensitivity not only of estrogen receptor–positive (ER(+))...

Descripción completa

Detalles Bibliográficos
Autores principales: Pesch, Andrea M., Hirsh, Nicole H., Michmerhuizen, Anna R., Jungles, Kassidy M., Wilder-Romans, Kari, Chandler, Benjamin C., Liu, Meilan, Lerner, Lynn M., Nino, Charles A., Ward, Connor, Cobain, Erin F., Lawrence, Theodore S., Pierce, Lori J., Rae, James M., Speers, Corey W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855810/
https://www.ncbi.nlm.nih.gov/pubmed/34932500
http://dx.doi.org/10.1172/jci.insight.154402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855810/
https://www.ncbi.nlm.nih.gov/pubmed/34932500
http://dx.doi.org/10.1172/jci.insight.154402

Ejemplares similares